Yield Growth to Enter Booming Market with
Immunity-Boosting Mushroom Products
Vancouver, British Columbia, Canada -- February 27, 2020 --
InvestorsHub NewsWire -- The
Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE:YG3) ("Yield
Growth") subsidiary Flourish Mushroom Labs is pleased
to announce that the company has completed product development for
Ayurvedic mushroom coffees and Ayurvedic mushroom botanical shots
for smoothies.
Flourish Mushroom Labs Ayurvedic mushroom
coffee
"These formulations
provide powerful brain and immune-boosting benefits thanks to their
powerful antioxidant and nutrient-rich formulas," said Penny White,
CEO of The Yield Growth Corp. "Along with their powerful health
profile, these products are made with fair-trade, organic
ingredients."
The Ayurvedic coffees and botanical
shots are planned for launch in early summer of 2020 and contain
immune-boosting medicinal mushrooms: reishi, chaga, lion's mane and
turkey tail. According to Mordor Intelligence, the global market
for functional mushrooms is forecasted to reach $34.3 billion by
2024, growing at a CAGR of 8.04% between 2019 and 2024.
"Immune-boosting
foods and supplements are in high demand throughout the cold and
flu season and are particularly important for anyone who is
especially susceptible to illness, including older individuals or
those with chronic conditions may be more vulnerable. The recent
Coronavirus outbreak has also sparked increased interest in
immune-boosting foods and supplements."
Chaga mushrooms have been used for
centuries in Siberia and Asia as medicine to reduce inflammation,
boost immunity and improve overall health. Chaga also has the
ability to lower high blood sugar and combat abnormal and mutagenic
cell growth.
Turkey Tail also contains a community
of powerful antioxidants and other compounds that may help boost
your immune system and may even fight certain cancers. Some
scientific studies have also shown that Turkey Tail may also
improve gut bacteria balance.
Reishi is one of the most popular
medicinal mushrooms and is known to be used to assist in weight
loss, boost immunity and fight certain cancer cells. What makes it
unique though are its calming properties thanks to a compound
called triterpene that it contains. This can help to promote
healing, sharpen focus, alleviate anxiety, ease depression, and
encourage better sleep.
Lion's Mane is also packed with antioxidants and also
strengthens the immune system, but it also has other unique
benefits that foster mental clarity and brain health. For example,
it aids in the production of the bioprotein nerve growth factor
(NFG) and myelin, which acts as "insulation" around nerve fibers
and helps to fight the onset of neurological diseases such as
Alzheimer's and multiple sclerosis.
"For centuries humans around the globe have used herbs and
plants to cure or prevent illness. Plants are the life force energy
for our food, oxygen, and medicine," said Bhavna Solecki, director
of product development for The Yield Growth Corp. "We are working
to bring these ancient traditions and plant-based remedies
mainstream."
The Ayurvedic shots contain herbs
such as holy basil and moringa.
Holy
basil, known as the "Queen of Herbs" helps to build natural
immunity, detoxify blood and promotes cellular regeneration. It
also acts as a strong antiseptic against many kinds of
disease-causing organisms, including bacteria, fungi, and
parasites.
Moringa is referred to as the "Tree of Life" in India. Moringa leaf
is a rich source of nutrients and antioxidants and has super
immune-boosting powers. It supports the liver as an antioxidant,
helps to relieve allergies and stomach disorders and also is known
to act as an antidepressant.
About Flourish Mushroom Labs
Inc.
Flourish Mushroom Labs aims to
legally and safely commercialize psilocybin (magic) mushrooms.
Flourish Mushroom Labs is planning to build a psilocybin mushroom
laboratory in St. Vincent and the Grenadines and is conducting
research into potentially therapeutic benefits of compounds found
in magic mushrooms. It has filed a U.S. patent application for the
use of psilocybin to aid in weight loss and treat obesity, diabetes
and to help prevent heart disease. Flourish also plans to be a
leader in the fast-growing medicinal mushrooms market-and improve
life by offering high-quality mushroom-infused products. Flourish
Mushroom Labs is a majority owned subsidiary of The Yield Growth
Corp.
About The Yield Growth
Corp.
The Yield Growth Corp. is a consumer
packaged goods company selling plant-based products with over 200
proprietary beauty, wellness, edibles and beverage formulas at
various stages of commercialization. It's products are sold through
e-commerce worldwide and retail stores in 3 countries with
distribution agreements in place for 12 more countries. It conducts
research for plant-based therapeutics and had 13 patents filed in
what the Global Wellness Institute reports is a $4.2
trillion-dollar global wellness market. It owns the hemp skin care
brand Urban Juve, which has been featured in UK Vogue and Elle
Canada, and it owns cannabis brands Wright & Well and Jack n
Jane. It's majority owned subsidiary Flourish Mushroom Labs is
launching a line of medicinal mushroom products and developing a
business in the emerging market of psychedelic medicine. The Yield
Growth management team has deep experience with global brands
including Johnson & Johnson, Procter & Gamble, Skechers and
Aritzia. Yield Growth earns revenue through multiple streams
including licensing, services and product sales.
For
more information about Yield Growth, visit www.yieldgrowth.com or follow @yieldgrowth on Instagram. Visit www.urbanjuve.com and #findyourjuve across
social platforms to learn, engage and shop.
Investor Relations
Contacts:
Penny White, President &
CEO
Kristina Pillon, Investor
Relations
invest@yieldgrowth.com
1-833-514-BOSS 1-833-514-2677
1-833-515-BOSS 1-833-515-2677
The Canadian Securities Exchange
has not reviewed, approved or disapproved the contents of this news
release.
Cautionary Statement
Regarding Forward-Looking Statements
This press release includes
forward-looking information and statements (collectively, "forward
looking statements") under applicable Canadian securities
legislation. Forward-looking statements are necessarily based upon
a number of estimates, forecasts, beliefs and assumptions that,
while considered reasonable, are subject to known and unknown
risks, uncertainties, and other factors which may cause actual
results and future events to differ materially from those expressed
or implied by such forward-looking statements. Such risks,
uncertainties and factors include, but are not limited to: risks
related to the development, testing, licensing, brand development,
availability of packaging, intellectual property protection,
reduced global commerce and reduced access to raw materials and
other supplies do to the spread of the Coronavirus, the potential
for not acquiring any rights as a result of the patent application
and any products making use of the intellectual property may be
ineffective or the company may be unsuccessful in commercializing
them; and other approvals will be required before commercial
exploitation of the intellectual property can happen. The laws
around cultivating, selling and using psychedelic mushrooms would
need to change in most jurisdictions in order for the use of
psychedelic products to be legal and sale of, and demand for, Urban
Juve, Wright & Well, Flourish Mushroom Labs, Jack n Jane and UJ
Beverages products, general business, economic, competitive,
political and social uncertainties, delay or failure to receive
board or regulatory approvals where applicable, and the state of
the capital markets. Yield Growth cautions readers not to place
undue reliance on forward-looking statements provided by Yield
Growth, as such forward-looking statements are not a guarantee of
future results or performance and actual results may differ
materially. The forward-looking statements contained in this press
release are made as of the date of this press release, and Yield
Growth expressly disclaims any obligation to update or alter
statements containing any forward-looking information, or the
factors or assumptions underlying them, whether as a result of new
information, future events or otherwise, except as required by
law.
Yield Growth (CSE:BOSS)
過去 株価チャート
から 11 2024 まで 12 2024
Yield Growth (CSE:BOSS)
過去 株価チャート
から 12 2023 まで 12 2024